References
- Adem, S., & Ciftci, M. (2012). Purification of rat kidney glucose 6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, and glutathione reductase enzymes using 2',5'-ADP Sepharose 4B affinity in a single chromatography step. Protein Expression and Purification, 81(1), 1–4. https://doi.org/https://doi.org/10.1016/j.pep.2011.08.031
- Akkemik, E., Budak, H., & Ciftci, M. (2010). Effects of some drugs on human erythrocyte glucose 6-phosphate dehydrogenase: An in vitro study. Journal of Enzyme Inhibition and Medicinal Chemistry, 25(6), 871–875. https://doi.org/https://doi.org/10.3109/14756360903489581
- Altikat, S., Ciftçi, M., & Büyükokuroğlu, M. E. (2002). In vitro effects of some anesthetic drugs on enzymatic activity of human red blood cell glucose 6-phosphate dehydrogenase. Polish Journal of Pharmacology, 54(1), 67–71.
- Atmaca, U., Kaya, R., Karaman, H. S., Celik, M., & Gulcin, I. (2019). Synthesis of oxazolidinone from enantiomerically enriched allylic alcohols and determination of their molecular docking and biologic activities. Bioorganic Chemistry, 88, 102980. https://doi.org/https://doi.org/10.1016/j.bioorg.2019.102980
- Bal, S., Kaya, R., Gök, Y., Taslimi, P., Aktaş, A., Karaman, M., & Gülçin, İ. (2020). Novel 2-methylimidazolium salts: Synthesis, characterization, molecular docking, and carbonic anhydrase and acetylcholinesterase inhibitory properties. Bioorganic Chemistry, 94, 103468. https://doi.org/https://doi.org/10.1016/j.bioorg.2019.103468
- Beutler, E. (1975). Red cell metabolism: a manual of biochemical methods. Grune and Stratton.
- Beydemir, S., Ciftçi, M., & Küfrevioğlu, O. I. (2002). Purification and characterization of glucose 6-phosphate dehydrogenase from sheep erythrocytes and inhibitory effects of some antibiotics on enzyme activity. Journal of Enzyme Inhibition and Medicinal Chemistry, 17(4), 271–277. https://doi.org/https://doi.org/10.1080/1475636021000010941
- Beydemir, S., Gulcin, I., Kufrevioglu, O. I., & Ciftci, M. (2003). Glucose 6-phosphate dehydrogenase: In vitro and in vivo effects of dantrolene sodium. Polish Journal of Pharmacology, 55(5), 787–792.
- Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248–254. https://doi.org/https://doi.org/10.1016/0003-2697(76)90527-3
- Bubp, J., Jen, M., & Matuszewski, K. (2015). Caring for glucose-6-phosphate dehydrogenase (G6PD)–deficient patients: implications for pharmacy. P and T Community, 40(9), 572–574.
- Ciftci, M., Kufrevioglu, O. I., Gundogdu, M., & Ozmen, I. I. (2000). Effects of some antibiotics on enzyme activity of glucose-6-phosphate dehydrogenase from human erythrocytes. Pharmacological Research, 41(1), 107–111. https://doi.org/https://doi.org/10.1006/phrs.1999.0566
- Ciftci, M., Senyayla, F., Ozdemir, H., & Buyukokuroglu, M. E. (2002). Some drug effects on the activity of erythrocyte hexokinase and glucose 6-phosphate dehydrogenase enzymes in vitro and in vivo. Polish Journal of Pharmacology, 54(6), 673–679.
- Correa, A., Rochlani, Y., & Aronow, W. S. (2020). Current pharmacotherapeutic strategies for cardiac arrhythmias in heart failure. Expert Opinion on Pharmacotherapy, 21(3), 339–352. https://doi.org/https://doi.org/10.1080/14656566.2019.1703950
- Farid, R., Day, T., Friesner, R. A., & Pearlstein, R. A. (2006). New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies. Bioorganic & Medicinal Chemistry, 14(9), 3160–3173. https://doi.org/https://doi.org/10.1016/j.bmc.2005.12.032
- Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/https://doi.org/10.1021/jm051256o
- Garcia, J., Han, D., Sancheti, H., Yap, L. P., Kaplowitz, N., & Cadenas, E. (2010). Regulation of mitochondrial glutathione redox status and protein glutathionylation by respiratory substrates. The Journal of Biological Chemistry, 285(51), 39646–39654. https://doi.org/https://doi.org/10.1074/jbc.M110.164160
- Halgren, T. A. (2009). Identifying and characterizing binding sites and assessing druggability. Journal of Chemical Information and Modeling, 49(2), 377–389. https://doi.org/https://doi.org/10.1021/ci800324m
- Hwang, S., Mruk, K., Rahighi, S., Raub, A. G., Chen, C. H., Dorn, L. E., Horikoshi, N., Wakatsuki, S., Chen, J. K., & Mochly-Rosen, D. (2018). Correcting glucose-6-phosphate dehydrogenase deficiency with a small-molecule activator. Nature Communications, 9(1), 4045. https://doi.org/https://doi.org/10.1038/s41467-018-06447-z
- Jiang, P., Du, W., Wang, X., Mancuso, A., Gao, X., Wu, M., & Yang, X. (2011). p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nature Cell Biology, 13(3), 310–316. https://doi.org/https://doi.org/10.1038/ncb2172
- Kalin, R., Koksal, Z., Kalin, P., Karaman, M., Gulcin, I., & Ozdemir, H. (2020). In vitro effects of standard antioxidants on lactoperoxidase enzyme-A molecular docking approach. Journal of Biochemical and Molecular Toxicology, 34(1), 1–8. https://doi.org/https://doi.org/10.1002/jbt.22421
- Karaman, M., Budak, H., & Ciftci, M. (2019). Amoxicillin and gentamicin antibiotics treatment adversely influence the fertility and morphology through decreasing the Dazl gene expression level and increasing the oxidative stress. Archives of Physiology and Biochemistry, 125(5), 447–455. https://doi.org/https://doi.org/10.1080/13813455.2018.1482354
- Kletzien, R. F., Harris, P. K., & Foellmi, L. A. (1994). Glucose-6-phosphate dehydrogenase: A "housekeeping" enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 8(2), 174–181. https://doi.org/https://doi.org/10.1096/fasebj.8.2.8119488
- Kotaka, M., Gover, S., Vandeputte-Rutten, L., Au, S. W., Lam, V. M., & Adams, M. J. (2005). Structural studies of glucose-6-phosphate and NADP + binding to human glucose-6-phosphate dehydrogenase. Acta Crystallographica. Section D, Biological Crystallography, 61(Pt 5), 495–504. https://doi.org/https://doi.org/10.1107/S0907444905002350
- Li, Q., Zhai, Z., & Li, J. (2020). Fibroblast growth factor homologous factors are potential ion channel modifiers associated with cardiac arrhythmias. European Journal of Pharmacology., 871, 172920. https://doi.org/https://doi.org/10.1016/j.ejphar.2020.172920
- Ninfali, P., Orsenigo, I., Baronciani, L., & Rapa, S. (1990). Rapid purification of glucose-6-phosphate dehydrogenase from mammal's erythrocytes. Preparative Biochemistry, 20(3-4), 297–309. https://doi.org/https://doi.org/10.1080/00327489008050202
- Nkhoma, E. T., Poole, C., Vannappagari, V., Hall, S. A., & Beutler, E. (2009). The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis. Blood Cells, Molecules & Diseases, 42(3), 267–278. https://doi.org/https://doi.org/10.1016/j.bcmd.2008.12.005
- Ozdemir, H., & Ciftci, M. (2006). In vitro effects of some drugs on human red blood cell glucose-6-phosphate dehydrogenase enzyme activity. Journal of Enzyme Inhibition and Medicinal Chemistry, 21(1), 75–80. https://doi.org/https://doi.org/10.1080/14756360500356790
- Ozmen, I., & Kufrevioglu, O. I. (2004). Effects of antiemetic drugs on glucose 6-phosphate dehydrogenase and some antioxidant enzymes. Pharmacological Research, 50(5), 499–504. https://doi.org/https://doi.org/10.1016/j.phrs.2004.05.007
- Pari, L., Murugavel, P., Sitasawad, S. L., & Kumar, K. S. (2007). Cytoprotective and antioxidant role of diallyl tetrasulfide on cadmium induced renal injury: An in vivo and in vitro study. Life Sciences, 80(7), 650–658. https://doi.org/https://doi.org/10.1016/j.lfs.2006.10.013
- Patra, K. C., & Hay, N. (2014). The pentose phosphate pathway and cancer. Trends in Biochemical Sciences, 39(8), 347–354. https://doi.org/https://doi.org/10.1016/j.tibs.2014.06.005
- Portaccio, M., Stellato, S., Rossi, S., Bencivenga, U., Mohy Eldin, M. S., Gaeta, F. S., & Mita, D. G. (1998). Galactose competitive inhibition of β-galactosidase (Aspergillus oryzae) immobilized on chitosan and nylon supports. Enzyme and Microbial Technology, 23(1-2), 101–106. https://doi.org/https://doi.org/10.1016/S0141-0229(98)00018-0
- Raub, A. G., Hwang, S., Horikoshi, N., Cunningham, A. D., Rahighi, S., Wakatsuki, S., & Mochly-Rosen, D. (2019). Small-molecule activators of glucose-6-phosphate dehydrogenase (G6PD) bridging the dimer interface. ChemMedChem, 14(14), 1321–1324. https://doi.org/https://doi.org/10.1002/cmdc.201900341
- Ribarov, S., & Benov, L. (1985). Glutathione reductase and glucose-6-phosphate dehydrogenase in erythrocytes treated with heavy metals. Acta Physiologica et Pharmacologica Bulgarica, 11(3), 51–54.
- Roden, D. M., & Iansmith, D. H. (1987). Effects of low potassium or magnesium concentrations on isolated cardiac tissue. The American Journal of Medicine, 82(3A), 18–23. https://doi.org/https://doi.org/10.1016/0002-9343(87)90128-8
- Sahin, A., Senturk, M., Ciftci, M., Varoglu, E., & Kufrevioglu, O. I. (2010). The effects of chemical and radioactive properties of Tl-201 on human erythrocyte glucose 6-phosphate dehydrogenase activity . Nuclear Medicine and Biology, 37(3), 389–394. https://doi.org/https://doi.org/10.1016/j.nucmedbio.2009.11.005
- Stanton, R. C. (2012). Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life, 64(5), 362–369. https://doi.org/https://doi.org/10.1002/iub.1017
- Tang, B. L. (2019). Neuroprotection by glucose-6-phosphate dehydrogenase and the pentose phosphate pathway. Journal of Cellular Biochemistry, 120(9), 14285–14295. https://doi.org/https://doi.org/10.1002/jcb.29004
- Taslimi, P., Türkan, F., Cetin, A., Burhan, H., Karaman, M., Bildirici, I., Gulçin, İ., & Şen, F. (2019). Pyrazole[3,4-d]pyridazine derivatives: Molecular docking and explore of acetylcholinesterase and carbonic anhydrase enzymes inhibitors as anticholinergics potentials. Bioorganic Chemistry, 92, 103213. https://doi.org/https://doi.org/10.1016/j.bioorg.2019.103213
- Temel, Y., Ayna, A., Hamdi Shafeeq, I., & Ciftci, M. (2020). In vitro effects of some antibiotics on glucose-6-phosphate dehydrogenase from rat (Rattus norvegicus) erythrocyte. Drug and Chemical Toxicology, 43(2), 219–223. https://doi.org/https://doi.org/10.1080/01480545.2018.1481083
- Tian, W. N., Braunstein, L. D., Apse, K., Pang, J., Rose, M., Tian, X., & Stanton, R. C. (1999). Importance of glucose-6-phosphate dehydrogenase activity in cell death. The American Journal of Physiology, 276(5), C1121–1131. https://doi.org/https://doi.org/10.1152/ajpcell.1999.276.5.C1121
- Tian, W. N., Braunstein, L. D., Pang, J., Stuhlmeier, K. M., Xi, Q. C., Tian, X., & Stanton, R. C. (1998). Importance of glucose-6-phosphate dehydrogenase activity for cell growth. The Journal of Biological Chemistry, 273(17), 10609–10617. https://doi.org/https://doi.org/10.1074/jbc.273.17.10609
- Turkan, F., Cetin, A., Taslimi, P., Karaman, H. S., & Gulcin, I. (2019). Synthesis, characterization, molecular docking and biological activities of novel pyrazoline derivatives. Archiv der Pharmazie, 352(6), e1800359. https://doi.org/https://doi.org/10.1002/ardp.201800359
- Waller, J. R., & Waller, D. G. (2014). Drugs for heart failure and arrhythmias. Medicine, 42(10), 620–624. https://doi.org/https://doi.org/10.1016/j.mpmed.2014.07.016
- Yen, W. C., Wu, Y. H., Wu, C. C., Lin, H. R., Stern, A., Chen, S. H., Shu, J. C., & Tsun-Yee Chiu, D. (2020). Impaired inflammasome activation and bacterial clearance in G6PD deficiency due to defective NOX/p38 MAPK/AP-1 redox signaling. Redox Biology, 28, 101363. https://doi.org/https://doi.org/10.1016/j.redox.2019.101363
- Yiğit, B., Kaya, R., Taslimi, P., Işık, Y., Karaman, M., Yiğit, M., Özdemir, İ., & Gulçin, İ. (2019). Imidazolinium chloride salts bearing wingtip groups: Synthesis, molecular docking and metabolic enzymes inhibition. Journal of Molecular Structure, 1179, 709–718. https://doi.org/https://doi.org/10.1016/j.molstruc.2018.11.038
- Youngster, I., Arcavi, L., Schechmaster, R., Akayzen, Y., Popliski, H., Shimonov, J., Beig, S., & Berkovitch, M. (2010). Medications and glucose-6-phosphate dehydrogenase deficiency: An evidence-based review. Drug Safety, 33(9), 713–726. https://doi.org/https://doi.org/10.2165/11536520-000000000-00000